BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8053954)

  • 1. Genetic typing of patients with inflammatory arthritis at presentation can be used to predict outcome.
    Gough A; Faint J; Salmon M; Hassell A; Wordsworth P; Pilling D; Birley A; Emery P
    Arthritis Rheum; 1994 Aug; 37(8):1166-70. PubMed ID: 8053954
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associations of HLA-DRB and -DQB genes with two and five year outcome in rheumatoid arthritis.
    Eberhardt K; Fex E; Johnson U; Wollheim FA
    Ann Rheum Dis; 1996 Jan; 55(1):34-9. PubMed ID: 8572731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HLA-DR/DQ interaction in patients with erosive rheumatoid arthritis presenting articular and extraarticular disease manifestations.
    Seidl C; Kässer UR; Fischer B; Koch U; Meier L; Fischer P; Wisseler HM; Faust-Tinnefeldt G; Bach G; Maas D; Bolten WW; Badenhoop K; Seifried E; Kaltwasser JP
    Eur J Immunogenet; 1999 Feb; 26(1):19-27. PubMed ID: 10068910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Seronegative and weakly seropositive rheumatoid arthritis differ from clearly seropositive rheumatoid arthritis in HLA class II associations.
    Ploski R; Mellbye OJ; Rønningen KS; Førre O; Thorsby E
    J Rheumatol; 1994 Aug; 21(8):1397-402. PubMed ID: 7983637
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Erosive rheumatoid factor negative and positive rheumatoid arthritis are immunogenetically similar.
    Vehe RK; Nepom GT; Wilske KR; Stage D; Begovich AB; Nepom BS
    J Rheumatol; 1994 Feb; 21(2):194-6. PubMed ID: 8182623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA heterozygosity contributes to susceptibility to rheumatoid arthritis.
    Wordsworth P; Pile KD; Buckely JD; Lanchbury JS; Ollier B; Lathrop M; Bell JI
    Am J Hum Genet; 1992 Sep; 51(3):585-91. PubMed ID: 1496989
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dw14(DRB1*0404) is a Dw4-dependent risk factor for rheumatoid arthritis. Rethinking the "shared epitope" hypothesis.
    Nelson JL; Mickelson E; Masewicz S; Barrington R; Dugowson C; Koepsell T; Hansen JA
    Tissue Antigens; 1991 Oct; 38(4):145-51. PubMed ID: 1724805
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of QK/QR/RRRAA or DERAA motifs at the third hypervariable region of HLA-DRB1 and disease severity in rheumatoid arthritis.
    Khani-Hanjani A; Lacaille D; Horne C; Chalmers A; Hoar DI; Balshaw R; Keown PA
    J Rheumatol; 2002 Jul; 29(7):1358-65. PubMed ID: 12136889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatoid arthritis in Israeli Jews: shared sequences in the third hypervariable region of DRB1 alleles are associated with susceptibility.
    Gao X; Gazit E; Livneh A; Stastny P
    J Rheumatol; 1991 Jun; 18(6):801-3. PubMed ID: 1895259
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA markers and prediction of clinical course and outcome in rheumatoid arthritis.
    Wagner U; Kaltenhäuser S; Sauer H; Arnold S; Seidel W; Häntzschel H; Kalden JR; Wassmuth R
    Arthritis Rheum; 1997 Feb; 40(2):341-51. PubMed ID: 9041946
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Independent association of rheumatoid factor and the HLA-DRB1 shared epitope with radiographic outcome in rheumatoid arthritis.
    Mattey DL; Hassell AB; Dawes PT; Cheung NT; Poulton KV; Thomson W; Hajeer AH; Ollier WE
    Arthritis Rheum; 2001 Jul; 44(7):1529-33. PubMed ID: 11465703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HLA-DRB1 genotype influences risk for and severity of rheumatoid arthritis.
    Meyer JM; Evans TI; Small RE; Redford TW; Han J; Singh R; Moxley G
    J Rheumatol; 1999 May; 26(5):1024-34. PubMed ID: 10332964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smoking increases rheumatoid arthritis susceptibility in individuals carrying the HLA-DRB1 shared epitope, regardless of rheumatoid factor or anti-cyclic citrullinated peptide antibody status.
    Bang SY; Lee KH; Cho SK; Lee HS; Lee KW; Bae SC
    Arthritis Rheum; 2010 Feb; 62(2):369-77. PubMed ID: 20112396
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of erosive arthritis with anti-cyclic citrullinated peptide antibodies and MHC Class II alleles in systemic lupus erythematosus.
    Chan MT; Owen P; Dunphy J; Cox B; Carmichael C; Korendowych E; McHugh NJ
    J Rheumatol; 2008 Jan; 35(1):77-83. PubMed ID: 18085741
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of HLA-DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factor in rheumatoid arthritis.
    Perdriger A; Chalès G; Semana G; Guggenbuhl P; Meyer O; Quillivic F; Pawlotsky Y
    J Rheumatol; 1997 Jul; 24(7):1272-6. PubMed ID: 9228123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of MHC class II genes in the etiopathogenesis of rheumatoid arthritis].
    Lacki JK; Korczowska I; Mackiewicz SH
    Przegl Lek; 1998; 55(10):524-7. PubMed ID: 10224866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of HLA-DR4-Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population.
    Yelamos J; Garcia-Lozano JR; Moreno I; Aguilera I; Gonzalez MF; Garcia A; Nuñez-Roldan A; Sanchez B
    Arthritis Rheum; 1993 Jun; 36(6):811-4. PubMed ID: 8507223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between HLA class II genes and autoantibodies to cyclic citrullinated peptides (CCPs) influences the severity of rheumatoid arthritis.
    van Gaalen FA; van Aken J; Huizinga TW; Schreuder GM; Breedveld FC; Zanelli E; van Venrooij WJ; Verweij CL; Toes RE; de Vries RR
    Arthritis Rheum; 2004 Jul; 50(7):2113-21. PubMed ID: 15248208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dw14 is a Dw4-independent risk factor for rheumatoid arthritis among Norwegians.
    Rønningen KS; Ploski R; Hansen T; Thorsby E
    Tissue Antigens; 1992 May; 39(5):280. PubMed ID: 1412414
    [No Abstract]   [Full Text] [Related]  

  • 20. Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis.
    Perdriger A; Guggenbuhl P; Chalès G; Yaouanq J; Quelvennec E; Bonnard MN; Pawlotsky Y; Semana G
    Rheumatology (Oxford); 1999 May; 38(5):448-52. PubMed ID: 10371284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.